Studies were selected if they were double blind RCTs that compared celecoxib at a licensed therapeutic dose for ≥12 weeks with placebo or another NSAID in patients with active RA or OA. 1 reviewer ...

Luyten and colleagues' prospective, randomized, multicenter, double-blind trial, therefore, compared continuous and intermittent celecoxib for the treatment of OA. All 123 patients had a flare of ...